WO2018198039A8 - Topical skin care compositions - Google Patents

Topical skin care compositions Download PDF

Info

Publication number
WO2018198039A8
WO2018198039A8 PCT/IB2018/052866 IB2018052866W WO2018198039A8 WO 2018198039 A8 WO2018198039 A8 WO 2018198039A8 IB 2018052866 W IB2018052866 W IB 2018052866W WO 2018198039 A8 WO2018198039 A8 WO 2018198039A8
Authority
WO
WIPO (PCT)
Prior art keywords
skin
skin care
care compositions
topical skin
topical
Prior art date
Application number
PCT/IB2018/052866
Other languages
French (fr)
Other versions
WO2018198039A1 (en
Inventor
Lalatendu Panigrahi
Alok Ranjan SAMAL
Uma Sowjanya Asapu
Deepanjan Datta
Vishal GALANDE
Chinmoy ROY
Original Assignee
Dr. Reddy's Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Limited filed Critical Dr. Reddy's Laboratories Limited
Priority to EA201992547A priority Critical patent/EA039464B1/en
Priority to UAA201911454A priority patent/UA122755C2/en
Publication of WO2018198039A1 publication Critical patent/WO2018198039A1/en
Publication of WO2018198039A8 publication Critical patent/WO2018198039A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a topical skin care composition comprising niacinamide, glycyrrhetinic acid, filagrinol and pseudo-ceramide and one or more pharmaceutically acceptable excipients. The skin care compositions further comprise one or more butters, one or more emulsifying agents and water as excipients. Methods of preparing such compositions are also provided. The present invention further relates to use of topical skin care compositions for the treatment and prevention psoriasis, atopic dermatitis or other skin disorders such as dry skin, eczema, red skin, inflamed skin, and/or cracked skin, for the relief of itching and the restoration of the affected areas of skin to a normal condition.
PCT/IB2018/052866 2017-04-26 2018-04-25 Topical skin care compositions WO2018198039A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EA201992547A EA039464B1 (en) 2017-04-26 2018-04-25 Topical skin care compositions
UAA201911454A UA122755C2 (en) 2017-04-26 2018-04-25 Topical skin care compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741014815 2017-04-26
IN201741014815 2017-04-26

Publications (2)

Publication Number Publication Date
WO2018198039A1 WO2018198039A1 (en) 2018-11-01
WO2018198039A8 true WO2018198039A8 (en) 2019-12-12

Family

ID=63918153

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/052866 WO2018198039A1 (en) 2017-04-26 2018-04-25 Topical skin care compositions

Country Status (3)

Country Link
EA (1) EA039464B1 (en)
UA (1) UA122755C2 (en)
WO (1) WO2018198039A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110037962A (en) * 2019-05-27 2019-07-23 贝德氏（上海）健康科技股份有限公司 A kind of face cream of whitening spot-removing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299264B1 (en) * 1998-05-15 2000-02-29 Codex V S R L TOPICAL PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SKIN DISEASES ON AN INFLAMMATORY, IMMUNE OR PROLIFERATIVE BASIS
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
EP2542246A1 (en) * 2010-03-03 2013-01-09 Neocutis SA Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
US8623330B2 (en) * 2010-03-18 2014-01-07 Precision Dermatology, Inc. Emollient foams for treatment of seborrheic dermatitis
WO2015013634A1 (en) * 2013-07-25 2015-01-29 Eberting Cheryl Lee Formulations for epidermal repair

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110037962A (en) * 2019-05-27 2019-07-23 贝德氏（上海）健康科技股份有限公司 A kind of face cream of whitening spot-removing

Also Published As

Publication number Publication date
WO2018198039A1 (en) 2018-11-01
EA201992547A1 (en) 2020-02-25
UA122755C2 (en) 2020-12-28
EA039464B1 (en) 2022-01-31

Similar Documents

Publication Publication Date Title
CN111601610A8 (en) Compositions and methods for treating diseases using strains of BlueTorilis
WO2017132432A8 (en) Benzimidazole derivatives as modulators of ror-gamma
PH12017502092A1 (en) Topical pharmaceutical compositions
PH12019500845A1 (en) Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
AU2018264384A1 (en) Solid forms of berberine ursodeoxycholate and compositions and methods thereof
WO2018111315A8 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
WO2020212760A3 (en) Compounds and methods for the treatment of ocular disorders
NZ759173A (en) Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
MX365366B (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne.
PH12020551555A1 (en) Calpain modulators and therapeutic uses thereof
EP4252755A3 (en) Therapeutic compounds
SA113340494B1 (en) Composition for treating metabolic disorders
MY160377A (en) Topical pharmaceutical compositions
WO2018198039A8 (en) Topical skin care compositions
MX2016016400A (en) Stabilized oxymetazoline formulations and their uses.
MX2021012353A (en) Topical cosmetic composition and uses thereof.
MX2020010302A (en) Use of (1s,3s)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (s)-3-amino-4-(difluoromethyl enyl)cyclopent-1-ene-1-carboxylic acid in the treatment of eye disorders.
MX2022013396A (en) Tetrahydroisoquinoline compounds as nrf2 activators.
CA2893966C (en) Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids
MX2020005238A (en) Compounds as mpges-1 inhibitors.
WO2023038968A3 (en) Compositions and methods to treat skin disorders
WO2017142368A3 (en) Composition for preventing and treating allergic or inflammatory skin disease
WO2021011875A8 (en) Compositions and methods for treating skin conditions
MX2022013398A (en) Tetrahydroisoquinoline compounds as nrf2 activators.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18791187

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18791187

Country of ref document: EP

Kind code of ref document: A1